In search of predictive and response markers in antiangiogenic therapy of glioblastoma

Neuro Oncol. 2021 Feb 25;23(2):184-185. doi: 10.1093/neuonc/noaa293.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Bevacizumab / therapeutic use
  • Brain Neoplasms* / drug therapy
  • Glioblastoma* / drug therapy
  • Humans
  • Magnetic Resonance Imaging
  • Perfusion

Substances

  • Angiogenesis Inhibitors
  • Bevacizumab